Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis
Sanja Stanojevic(University of North Carolina at Chapel Hill), Félix Ratjen(Boston Children's Hospital), Sylvia Jara(Riley Hospital for Children), Michelle Shaw(SickKids Foundation), Hartmut Grasemann(Boston Children's Hospital), Charles Clem(Riley Hospital for Children), Nancy McDonald(Lucile Packard Children's Hospital), Lisa France(University of North Carolina at Chapel Hill), Stephanie D. Davis(University of North Carolina at Chapel Hill), Lucy Perrem(Children's Health Ireland at Crumlin), Melinda Solomon(Hospital for Sick Children), Neil Sweezey(Hospital for Sick Children), Renée Jensen(University of North Carolina at Chapel Hill), Sarah Isaac(Hospital for Sick Children), Miriam Davis(Riley Hospital for Children), Julia Guido(SickKids Foundation), George Retsch‐Bogart(University of North Carolina at Chapel Hill), Valerie Waters(University of Toronto), Don B. Sanders(Indiana University Bloomington)
Cited by 27
Related Papers
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k
The Effect of Chronic Infection With Aspergillus fumigatus on Lung Function and Hospitalization in Patients With Cystic Fibrosis
|CHEST Journal|2009|372
Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues
|Journal of Cystic Fibrosis|2024|77
Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome
|European Respiratory Journal|1999|69
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2020|50